Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback